Targeted Sequencing Provides Clues to Treatment Failure in Acute Lymphoblastic Leukemia
April 05, 2011
Targeted Sequencing Provides Clues to Treatment Failure in Acute Lymphoblastic Leukemia
Researchers at St. Jude Children's Research Hospital found that even limited DNA sequencing can provide clues for more effective ALL treatments, and believe that more comprehensive sequencing could deliver additional clinically relevant results.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Clinical Genome Sequencing Requires Better Standards for Accuracy, Completeness, NHGRI Team Says
August 24, 2011 / Clinical Sequencing News - Illumina and University of Oxford to Sequence 500 Human Genomes to Inform Diagnosis, Treatment
August 3, 2011 / Clinical Sequencing News - Prepping for Summer Launch of Trisomy 21 Test, LifeCodexx Eyes Additional Indications
May 23, 2012 / Clinical Sequencing News - Sequencing Study Suggests Potential New Treatments for ALL Subset with Poor Response
January 25, 2012 / Pharmacogenomics Reporter - Verinata Bets on Illumina HiSeq 2000 for Non-Invasive Prenatal Aneuploidy Test
October 5, 2011 / Clinical Sequencing News